Polymorphisms of nuclear factor- B family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens

Abstract

Nuclear factor-κB family member gene polymorphisms play a role in the development of multiple myeloma and in the response to bortezomib therapy.